|
|
Lotus Readies Generic Angina Drug
publication date: Feb 6, 2008
Lotus Pharmaceuticals, Inc. (OTCBB: LTUS) reported that its isosorbide mononitrate sustained release tablet, a generic version of angina drug Imdur from AstraZeneca (NYSE: AZN), produced positive results in a clinical trial. Data from the trial were not released, but promised. Lotus expects to submit the drug to the SFDA and, if approved, launch it in 2009. We look at the drug and at Lotus. More details...
Stock Symbol: (OTCBB: LTUS) (NYSE: AZN)
|
ChinaBio® Events
ChinaBio® Partnering Forum 2012May 23-24, 2012 Suzhou, China >>More events...
Partner Events
 China Healthcare Investment Conference 2012March 13-15, 2012 Shanghai, China Shanghai CEO ConferenceMarch 28-29, 2012 Shanghai, China >>More details...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners
![]()
|